top of page

Welcome to Season 5 of the award-winning Precision Medicine Podcast

Clinical conversations about the effective use of precision medicine for cancer care.


Get the latest episode straight to your in-box.

Gold Site Bug.png
Season 5
Dr. Debra Patt: Texas Oncology Has an “Easy Button” for Delivering Consistent Precision Oncology Care

To mark the beginning of Season 5, we are honored to welcome Dr. Debra Patt, Executive Vice President of Texas Oncology. As an breast cancer specialist at one of the nation’s largest community cancer practices, Dr. Patt is on the frontlines of oncology care every day. She joins us to discuss how Texas Oncology uses clinical decision-support technologies and health economics and health services research to deliver more consistent precision oncology care to patients at over 200 locations across Texas. Listen here

Airdate: 12.12.22   |   Length: 27:40

Season 4
Do We Have the Will to Address Inequality in Precision Oncology? A conversation with Dr. Karen Winkfield

In this episode, we are joined by Dr. Karen Winkfield, Executive Director of the Meharry-Vanderbilt Alliance, appointee to President Joe Biden's National Cancer Advisory Board, and co-host of the weekly podcast, 3 Black Docs, which is dedicated to educating the community about health and health disparities in an approachable and entertaining way. Listen here

Airdate: 06.03.22   |   Length: 52:40

Stephen Kingsmore headshot_02.png
Dr. Stephen Kingsmore on Scaling Whole-Genome Sequencing for Uncovering Genetic Defects in Infants

In episode 55 of the Precision Medicine Podcast, we welcome Dr. Stephen Kingsmore, President and CEO of the Rady Children's Institute for Genomic Medicine. Dr. Kingsmore joins us to discuss the extraordinary role whole-genome sequencing is playing in prolonging and improving the life of critically ill newborns. Listen here

Airdate: 03.29.22   |   Length: 38:19

Rolfo_Headshot 2021 .png
Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine

Dr. Christian Rolfo, President of the International Society of Liquid Biopsy and Associate Director for Clinical Research at the Center of Thoracic Oncology at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City, joins us to explain the unique role liquid biopsies are playing in the diagnosis and treatment of cancer. Listen here

Airdate: 02.16.22   |   Length: 30:52


Airdate: 01.22.22   |   Length: 40:12

LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing

In this Precision Medicine Podcast episode, we are joined by Dr. Belinda King-Kallimanis, Director of Patient-Focused Research at LUNGevity—an organization that brings together research, education and support services for patients and caregivers in the lung cancer community—and Nichelle Stigger, LUNGevity board member and lung cancer survivor. They sat down with us to discuss everything from the importance of patient-friendly language in lung cancer to discrepancies in access to biomarker testing and what LUNGevity is doing to improve the status quo. Listen here

Hannah headshot 2020_Edit.png

Airdate: 11.19.21   |   Length: 34:52

Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky of Alva10

In celebration of the three-year anniversary of the Precision Medicine Podcast, we take a look back at how far precision diagnostics have come with the help of one of our first guests Hannah Mamuszka (episode 3), Founder and CEO of Alva10, and her colleague Lena Chaihorsky. Both women are focused on resolving the knowledge gap between payers and diagnostic companies and moving diagnostics to the forefront of the precision medicine conversation. Listen here

Season 3
Author and Breast Cancer “Previvor” Ali Rogin on How Progress in Precision Medicine Empowers Patients to Make Informed Decisions

In honor of Breast Cancer Awareness Month, we speak with Ali Rogin, author of Beat Breast Cancer Like a Boss and award-winning producer of PBS NewsHour who shares her personal story as a breast cancer previvor. Ali says the progress in precision medicine and genetic testing has given women and men with a predisposition for the disease options they would never have had before, enabling them to make proactive, informed decisions about their future health. Listen here

Airdate: 10.01.21   |   Length: 30:31

Kashyap Patel_3_Edit.png
Dr. Kashyap Patel Tackles Oncology Treatment Disparities and Brings Light to the Darkest Areas of Cancer Care

For our 50th episode, we welcome Dr. Kashyap Patel, medical oncologist and CEO of Carolina Blood and Cancer Center, current president of the Community Oncology Alliance, and author of a new book, Between Life and Death: From Despair to Hope. Dr. Patel explains the social determinants that can impact the quality of care and opportunity for precision medicine that patients—and specifically oncology patients—receive. For him, Covid-19 brought to light the impact that disparities in healthcare can have for all of us. Listen here

Airdate: 08.27.21   |   Length: 30:31

Janine Morales, PhD On Applying Precision Medicine More Strategically With Molecular Testing

In this episode, Janine Morales, PhD, Chief Scientific Officer at Trapelo Health takes us inside the complex world of evidence-based decision making in oncology. Specifically, she explains how having access to a real-time knowledgebase and a team of experts that curate current clinical evidence can empower providers to make more appropriate decisions at the point of careListen here

Airdate: 07.28.21   |   Length: 32:21

Dr. Howard McLeod on Chasing the Fun and the Power of Collaboration in Precision Medicine

We cover a lot of ground with Dr. McLeod, Medical Director for Precision Medicine at The Geriatric Oncology Consortium, in this podcast including career advice, the advancement of precision medicine technology and the positive impact of COVID on telemedicine and clinical trials. Read the full summary and tune in to the audio below. Listen here

Airdate: 06.17.21   |   Length: 40:16

Bill Bonello.jpg
Bill Bonello and Clynt Taylor Examine the Future of Precision Medicine and How to Provide Better Access to More Patients


Leaders from NeoGenomics Informatics and Trapelo Health discuss challenges in precision medicine and how evidence-based technologies can help deliver more appropriate, value-based care to more patients. As a subtext is the recent acquisition of Trapelo Health which is aimed at improving access to precision medicine testing and treatment. Listen here

Airdate: 05.12.21   |   Length: 29:16

Dr. Caroline Carney and Clynt Taylor Discuss Managing the Total Cost of Care in Precision Medicine


In this notable episode, Dr. Caroline Carney, Chief Medical Officer at Magellan Health, and Clynt Taylor, Trapelo Health CEO, join us to discuss how collaborative technologies can help payers more effectively manage the cost of precision oncology while delivering the best outcomes for patients. Listen here

Airdate: 04.08.21   |   Length: 32:22

Dr Greco Headshot.png
Dr. F. Anthony Greco Explains How Precision Medicine Has Led to Better Treatments for Cancers of Unknown Origins


Dr. F. Anthony Greco, medical oncologist at Tennessee Oncology, to discuss the role that precision medicine has played in improving our diagnosis and treatment of cancer. Listen here

Airdate: 03.30.21   |   Length: 33:18

bienwillner-3111 digital_Crop.png
Dr. Gabriel Bien-Willner Part 2: Helping Payers Adapt to the Paradigm Shift of Precision Medicine


Dr. Gabriel A. Bien-Willner, Medical Director of the MolDX program at Palmetto GBA, dives into the core challenges that payers face in navigating the explosion of precision medicine tests and treatments, and how the prior authorization process can be streamlined for better workflow and patient outcomes.  Listen here

Airdate: 02.22.21   |   Length: 25:28

AbbVie’s Christopher Boone Integrates Real-World Data with Precision Medicine for Better Patient Outcomes


In this episode, we talk with Christopher Boone, Vice President and Global Head of Health Economics & Outcomes Research at AbbVie, to hear his thoughts on how using data to understand a patient’s real-world environment can expand the practice of precision medicine Listen here

Airdate: 01.22.21   |   Length: 36:14

Clynt pic 3.3_edited.png
Precision Medicine is Coming Faster Than You Think: Guests Rob Metcalf and Clynt Taylor

Airdate: 12.10.20   |   Length: 28:30

In this first Season 3 episode, two innovators in precision medicine technology join us, Rob Metcalf, CEO of Concert Genetics and Clynt Taylor, CEO of Trapelo Health. What we learn from them is that after 20 years of hearing about the “promise of precision medicine,” technology has reached a critical point where it can begin to accelerate that progress. Listen here

How can we resolve the complexities of using precision medicine for cancer care?

Trapelo knows.

bottom of page